1. Home/
  2. Compounds/
  3. selumetinib:piperlongumine (8:1 mol/mol)

selumetinib:piperlongumine (8:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2selumetinib:piperlongumine (8:1 mol/mol)
PharmacoGx selumetinib:piperlongumine (8:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to selumetinib:piperlongumine (8:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA AC127070.1 CTRPv2 pan-cancer AAC -0.1 0.003
mRNA AC129492.1 CTRPv2 pan-cancer AAC 0.09 0.01
mRNA AC240274.1 CTRPv2 pan-cancer AAC -0.095 0.009
mRNA ACAA1 CTRPv2 pan-cancer AAC 0.13 0.0005
mRNA ACACA CTRPv2 pan-cancer AAC -0.089 0.01
mRNA ACAP1 CTRPv2 pan-cancer AAC -0.13 0.008
mRNA ACAP2 CTRPv2 pan-cancer AAC -0.087 0.01
mRNA ACAT1 CTRPv2 pan-cancer AAC -0.1 0.003
mRNA ACER2 CTRPv2 pan-cancer AAC 0.13 0.0003
mRNA ACOT11 CTRPv2 pan-cancer AAC 0.17 8e-06
Download CSV